UGM-26626-66972
3 vaccinations
2 coded responses
37 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
C94-71939-53644
Child or adolescent in my care · Female · 2022-06-27
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
-
2021-02-23
Dose 2 — Pfizer-BioNTech
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body achesAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
-
2021-03-09
Survey response — day 14, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-05-25
- 2021-08-24
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
-
2021-12-27
Survey response — 3 months, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to do your normal daily activitiesFree text: I've tested positive for CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-03-28
- 2022-09-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
Free text
Release 5 — day 14, dose 2
Symptoms: Headache
Release 10 — 3 months, dose 3
Symptoms: I've tested positive for Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release